Market Closed -
Canadian Securities Exchange
18:10:00 08/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.005
CAD
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
11.15
|
15.95
|
21.26
|
1.606
|
1.733
|
Enterprise Value (EV)
1 |
15.37
|
19.36
|
24.7
|
2.845
|
3.231
|
P/E ratio
|
-0.42
x
|
-2.49
x
|
-4.37
x
|
-0.62
x
|
-0.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
6,005,926
x
|
201,927,173
x
|
EV / Revenue
|
-
|
-
|
-
|
10,636,094
x
|
376,504,894
x
|
EV / EBITDA
|
-3.59
x
|
-3.7
x
|
-13.1
x
|
-1.8
x
|
-4.63
x
|
EV / FCF
|
-51.9
x
|
68,411
x
|
-17
x
|
-4.35
x
|
5.32
x
|
FCF Yield
|
-1.93%
|
0%
|
-5.87%
|
-23%
|
18.8%
|
Price to Book
|
17.5
x
|
5.25
x
|
275
x
|
-1.14
x
|
-0.46
x
|
Nbr of stocks (in thousands)
|
185,898
|
245,378
|
283,412
|
321,255
|
346,588
|
Reference price
2 |
0.0600
|
0.0650
|
0.0750
|
0.005000
|
0.005000
|
Announcement Date
|
15/06/20
|
30/04/21
|
02/05/22
|
03/05/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
0.2674
|
0.008582
|
EBITDA
1 |
-4.077
|
-4.281
|
-5.231
|
-1.878
|
-1.578
|
-0.6971
|
EBIT
1 |
-4.086
|
-4.331
|
-5.326
|
-2.538
|
-2.105
|
-0.9964
|
Operating Margin
|
-
|
-
|
-
|
-
|
-786.92%
|
-11,610.89%
|
Earnings before Tax (EBT)
1 |
-4.085
|
-24.56
|
-5.612
|
-4.623
|
-2.416
|
-2.449
|
Net income
1 |
-4.085
|
-24.56
|
-5.612
|
-4.623
|
-2.416
|
-2.449
|
Net margin
|
-
|
-
|
-
|
-
|
-903.36%
|
-28,531.72%
|
EPS
2 |
-0.4151
|
-0.1428
|
-0.0262
|
-0.0172
|
-0.008053
|
-0.009999
|
Free Cash Flow
1 |
0.3666
|
-0.296
|
0.000283
|
-1.449
|
-0.6544
|
0.6078
|
FCF margin
|
-
|
-
|
-
|
-
|
-244.68%
|
7,081.96%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/04/19
|
15/06/20
|
30/04/21
|
02/05/22
|
03/05/23
|
30/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
4.22
|
3.41
|
3.45
|
1.24
|
1.5
|
Net Cash position
1 |
0.14
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-0.986
x
|
-0.652
x
|
-1.834
x
|
-0.7848
x
|
-2.149
x
|
Free Cash Flow
1 |
0.37
|
-0.3
|
0
|
-1.45
|
-0.65
|
0.61
|
ROE (net income / shareholders' equity)
|
-1,497%
|
-4,510%
|
-303%
|
-294%
|
362%
|
95.2%
|
ROA (Net income/ Total Assets)
|
-709%
|
-88.3%
|
-50.1%
|
-24.8%
|
-38.7%
|
-73.4%
|
Assets
1 |
0.5762
|
27.81
|
11.19
|
18.63
|
6.236
|
3.338
|
Book Value Per Share
2 |
0.0300
|
0
|
0.0100
|
0
|
-0
|
-0.0100
|
Cash Flow per Share
2 |
0.0100
|
0
|
0
|
0
|
-
|
-
|
Capex
1 |
0.07
|
0.23
|
0.44
|
1.73
|
0.18
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
68.59%
|
-
|
Announcement Date
|
30/04/19
|
15/06/20
|
30/04/21
|
02/05/22
|
03/05/23
|
30/04/24
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 1.27M | | +40.09% | 6.16B | | -16.34% | 4.46B | | -7.11% | 3.27B | | +5.14% | 3.2B | | -0.18% | 2.6B | | +47.93% | 1.98B | | -7.15% | 1.7B | | +0.67% | 1.66B | | -8.73% | 1.61B |
Alternative Medicine
|